Climb Bio, Inc. <CLYM.O>: Oppenheimer Raises Target Price to $25 from $18
CLYM•Related News
DoorDash partners with SKIMS for on-demand delivery from US retail stores
DASH•
QEP acquires Spray-Lock assets, expands adhesives platform
QEPC•
Enbridge names Michele Harradence CEO, effective Jan. 1, 2027
ENB•
Interface earns Great Place To Work certification in all eligible operating countries
TILE•
Chemed to Present at Jefferies Healthcare Services and Technology Conference
CHE•